Streetbeat News

Products Services

POAI

Predictive Oncology Inc. (NASDAQ:POAI) has completed a multi-year study with UPMC Magee-Womens Hospital, using AI to build multi-omic machine learning models for ovarian cancer patient survival. The study used one of the largest sets of multi-omic data from 235 ovarian cancer patients. The models have the potential to become invaluable clinical support tools and could support the tailoring of therapies to individual patients.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:13 pm

SILO

Silo Pharma, Inc. (NASDAQ:SILO) has announced plans to initiate a dose-ranging study of its targeted prophylactic treatment SPC-15 for the treatment of post-traumatic stress disorder (PTSD). The study, in collaboration with AmplifyBio, will identify the maximum tolerated intranasal dose of the drug and pharmacokinetic in small animals. The final validation report is expected in 2024. If clinically successful, SPC-15 could qualify for the FDA's streamlined 505(b)(2) regulatory pathway for drug approval.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:11 pm

ONVO

Organovo Holdings, Inc. (NASDAQ:ONVO) announced its intention to study combination therapy in inflammatory bowel disease and release data in Q3 2024. The company is focused on developing FXR314, a drug that has shown promise in 3D human tissues and preclinical data. The company believes that FXR314 could complement other successful drugs in the space, such as Humira, Stelara, and Xeljanz, and could enable dosing half or less of the typical dose of these drugs, reducing the safety impact and better serving patients.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:11 pm

CDMO

Avid Bioservices, Inc. (NASDAQ:CDMO) has announced a partnership with the California Institute for Regenerative Medicine (CIRM) to provide development and CGMP manufacturing services to CIRM-funded programs. The collaboration aims to support the manufacturing of adeno-associated adenovirus (AAV), as well as other cell and gene therapy (CGT) programs within California. Avid will assist CIRM's partners in accelerating gene therapy development and manufacturing through its suite of CDMO services.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:09 pm

CHPT

ChargePoint (NYSE:CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), announced that it has reached one million quarterly active drivers on its network. To celebrate this milestone, the company has launched a major update to its driver app, which is used by millions of drivers to find, charge, and pay for their EV fueling. In the United States, two million EV drivers have used a ChargePoint account to start a charge, representing approximately half of US EV drivers.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:07 pm

TRU

The Department of Veterans Affairs (VA) has awarded a contract to TransUnion (NYSE:TRU) and its partner Four Points Technology to improve veterans' experiences when accessing key services. The contract will enable TransUnion to provide TruContact™ Trusted Call Solutions across VA contact centers, major medical centers, and major programs. The solution will help the VA deliver information about essential benefits at times that matter most and protect veterans from fraud by identifying and blocking spoofed calls.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:05 pm

GEHC

MASI

GE HealthCare (NASDAQ:GEHC) and Masimo (NASDAQ:MASI) have announced a collaboration to integrate Masimo's Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution. The integration will allow clinicians to use Masimo's oxygen saturation measurement technology to noninvasively detect and monitor changes in patient status. The announcement follows the FDA clearance of Portrait Mobile in August 2023.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:02 pm

SPOT

Spotify has announced that over 200,000 audiobooks are now available to its Premium subscribers in the U.S. This follows similar rollouts in the U.K. and Australia. The company is offering 15 hours of listening per month to each Premium individual and plan managers for Family and Duo accounts. The audiobook catalog includes over 70% of bestselling titles. The company also found that younger generations, particularly Gen Z and millennials, are increasingly listening to audiobooks.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:58 pm

AAPL

Apple Inc. is planning to discontinue the 12.9-inch iPad Pro and replace it with the M3-powered 13-inch iPad Pro, according to a report by TrendForce. The new iPad Pro will feature a 13-inch OLED display and is expected to launch in 2024. The switch to OLED is expected to offer better brightness, contrast, color accuracy, and power efficiency. Apple is also expected to update its iPad Air, iPad mini, and entry-level iPad models in 2024.

Portfolio Pulse from Rounak Jain

November 08, 2023 | 12:48 pm

AUVI

Applied UV's subsidiary, Sterilumen, has launched new air and HVAC disinfection solutions. This move could potentially increase the company's market share in the disinfection solutions industry.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:40 pm